default author photo

Adrien Holzgreve

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

46

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Dummy Run for Planning of Isotoxic Dose-Escalated Radiation Therapy for Glioblastoma Used in the Pride Trial (Noa-28; Aro-2024-01; Ag-Nro-06)

Number of pages: 28 Posted: 30 Mar 2024
affiliation not provided to SSRN, LMU University Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Charité - Universitätsmedizin Berlin, affiliation not provided to SSRN, affiliation not provided to SSRN, Universitätsklinikum Leipzig, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Heinrich Heine University Dusseldorf - Department of Radiation Oncology, Heinrich Heine University Dusseldorf - Department of Radiation Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ludwig Maximilian University of Munich (LMU) - Department of Radiation Oncology, Ludwig Maximilians University LMU University Hospital Munich, LMU University Hospital and affiliation not provided to SSRN
Downloads 46 (1,109,210)

Abstract:

Loading...

glioblastoma, Dose Escalation, PRIDE Trial, Bevacizumab, NTCP, FET PET, QA